TVTX
#1191
Travere Therapeutics, Inc. - Common Stock
66.2 8 USD
+0.01%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+0.93%
Variación mensual
+20.90%
Variación en los últimos 6 meses
+126.37%
Cambio anual
+130.38%
Cierres anteriores
65.6 7
Open
66.2 8
Mínimo
66.2 8
Máximo
66.2 8
Volumen
132
Financials
- Market Capitalization 6.25 B
- Employee 497
- Founded 2011
- CEO N/A
- Website www.travere.com
- Headquarter California, United States
- FIGI BBG000P9D6W9
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-126.24
Relación precio/flujo de caja
9.08
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1175 |  MIRM Mirum Pharmaceuticals, Inc. - common stock | 98.05 USD | +0.61% | -0.46% | -6.88% | +39.81% | 6.37 B USD | ||
| 1189 |  ERAS Erasca, Inc. - Common Stock | 17.88 USD | -0.83% | -0.39% | +0.68% | +1046.15% | 6.25 B USD | ||
| 1199 |  BLTE Belite Bio Inc - American Depositary Shares | 155.71 USD | +2.63% | -3.34% | -1.17% | +150.42% | 6.13 B USD | ||
| 1200 |  LQDA Liquidia Corporation - Common Stock | 68.17 USD | +0.71% | -4.66% | -17.08% | +201.64% | 6.10 B USD |